MAPK8IP1P2 and thyroid gland carcinoma: Thus MAPK8IP1P2 acts as an oncosuppressor lncRNA with anti-lymphangiogenic properties, inhibiting lymphatic metastasis in thyroid cancer via the activation of Hippo signaling [193].